http://www.mercola.com/article/mercury/mercury_elimination2.htm

Mercury Toxicity and Systemic Elimination Agents
 
Bibliography

1 Toxicological Profile For Mercury. U.S.Department Of Health & Human Services,
Agency for Toxic Substances and Disease Registry, March 1999 Published by
Division of Toxicology/Toxicology Information Branch, 1600 Clifton Road NE,
E-29, Atlanta, Georgia 3033

2 Richardson GM. Assessment of mercury exposure and risks from dental amalgam.
Medical Devices Bureau, Environmental Health Directorate, 1995 Health Canada.

3 Stajich GV, Lopez GP, Harry SW, et al. Iatrogenic exposure to mercury after
hepatitis B vaccination in preterm infants. J Pediatr. 2000 May;136(5):679-81.

4 Pless R, Risher JF. Mercury, infant neurodevelopment, and vaccination. J
Pediatr. Mercury, infant neurodevelopment, and vaccination. 2000
May;136(5):571-3.

5 Offit PA. Preventing harm from thimerosal in vaccines. JAMA. 2000 Apr
26;283(16):2104.

6 No authors listed. From the Centers for Disease Control and Prevention.
Recommendations regarding the use of vaccines that contain thimerosal as a
preservative. JAMA. 1999 Dec 8;282(22):2114-5.

7 Inouye M, Murakami U. Placental transfer of methylmercury and mercuric
mercury in mice. Environ Med 1990;34:160-172.

8 Kuntz WD, Pitkin RM, Bonstrom AW, et al. Maternal and cord blood background
levels. A longitudinal surveillance. Am J Obstet Gynecol 1982;143:440-443.

9. Harrison IA; Some electromchemical features of the in vivo corrosion of
dental amalgams. J Appl Electrochem 1989;19: 301-310
10 Marek M. Dissolution of mercury vapor in simulated oral environments. Dent
Mater 1997 Sep;13(5):312-5.

11 WHO. Inorganic Mercury. Geneva, Switzerland: World Health Organization,
International Programme on Chemical Safety. 1991 Vol 118.

12. Skare I, Engqvist A., Human exposure to mercury and silver released from
dental amalgam restorations. Arch Environ Hlth 1994;49:384-394

13. World Health Organization. Environmental Health Criteria. 118, Inorganic
Mercury (Friber I, ed) WHO Geneva 1991.

14. Berry TC, Nicholson J, Torendle K.; Almost two centuries with amalgam.
Where are we today? J Am Dent Assn 1994;120:394-395

15. Lorschider, F, Vimy MJ, Summers, AO: Mercury exposure from "silver" tooth
fillings: Emerging evidence questions a traditional dental paradigm. FASEB J
1995; 9:504-508

16. Lorscheider F, Vimy MJ: Evaluation of the safety issue of mercury release
from dental fillings. FASEB J 1993;7:1432-1433

17 Bjorkman L, Sandborgh-Englund G, Ekstrand J. Mercury in salvia and feces
after removal of amalgam fillings. Toxicol Apply Pharmacol 1997;144:156-162.

18. Svare CW, Peterson LC, Reinhardt JW, Boyer DB, et.al; The effects of dental
amalgams on mercury levels in expired air. J Dent Res 1981;60:1668-1671

19. Vimy MJ, Lorscheider F; Intra-oral air mercury released from dental
amalgam. J Dent Res 1985;64:10069-1071

20. Aronsson AM; Lind B, Nylander M, Nordberg M; Dental amalgam and mercury.
Biol Metals 1989; 2:25-30

21. Hanson M, Pleva J: The dental amalgam issue. A review. J Experentia.
1991;47:479-22

22 Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev
2000 Mar;52(1):113-43.

23. Hahn LJ, Kloiber R, Leininzer RW, Vimy MJ, Lorscheider FI; Whole-body
imaging of the distribution of mercury released from dental fillings into
monkey tissues. FASEB J 1990;4:3256-3260

24 Zahnaerztl, Knappwost et al. Abgabe von Quecksilberdampf aus Dentalamalgamen
unter Mundbedingungen. Welt/Reform 1985;94, 131-138

25. Nierenberg DW, Nordgren RE, Chang MB, et al. Delayed cerebellar disease and
death after accidental exposure to dimethylmercury. N Engl J Med. 1998;338(23):
1672-1676

26. Clarkson TW; Mercury - an element of mystery. N Engl J Med.
1990;323:1137-1139

27. The toxicological profile of mercury. 1994 publication by the US Department
of Health and Human Services (Agency for Toxic Substances and Disease Registry,
Division of Toxicology; 1600 Clifton Road NE E-29, Atlanta, GA 30333).

28. Eggleston DW, Nylander M.; Correlation of dental amalgam with mercury in
the brain. J Prost Dent 1987;58:704-707

29. Retrograde Axonal Transport of Mercury; Bjoern Arvidson Experimental
Neurology 1987;98, 198-203

30 Inorganic Mercury is Transported from Muscular Nerve Terminals to Spinal and
Brainstem Motorneurons: Bjoern Arvidson Muscle and Nerve 1992;15:1089-1094

31 Handbuch der Amalgamvergifung, Max Daunderer, Ecomed Verlag, Muenchen(1996)

32 Clarkson TW, Hursh IB, Sager PR, Sverson TLM: Mercury. In Biological
Monitoring of Toxic Metals (Clarkson TW, Friberg L, Nordberg CF,, and Sager PR,
eds) pp 199-246. Plenum, New York 1988.

33 Klassen CD. Heavy metals and heavy-metal antagonists. In: The
Pharmacological Basis of Theraputics, 8th edition(Gilman AC, Rall TW, Niew AS,
Taylor P, eds) pp. 1598-1602. Pergamon Press, New York 1990.

34 Pendergrass JC, Haley BE, Vimy MJ, et al. Mercury vapor inhalation inhibits
binding of GTP to tubulin in rat brain: similarity to a molecular lesion in
Alzheimer diseased brain. Neurotoxicology. 1997;18(2):315-24.

35 Pendergrass JC, Haley BE. Inhibition of brain tubulin-guanosine
5'-triphosphate interactions by mercury: similarity to observations in
Alzheimer's diseased brain. Met Ions Biol Syst. 1997;34:461-78.

36 Hirsch F, Kuhn J, Ventura M, Vial MC, Fournie G, Druet P; Production of
monoclonal antibodies. J Immunol 1986;136:3272-3276

37 Hultman P, Johansson U, Turley Sj, Lindh U, Enestrom S, Pollard KM; Adverse
immunological effects and autoimmunity induced by dental amalgam and alloy in
mice. FASEB J 1994;8:1183-1190

38 Biagazzi M, Pierlguigi E; Autoimmunity and heavy metals. Lupus
1994;3:449-453.

39 Nylander M, Frierg I, Lind B; Mercury concentrations in the human brain and
kidneys in relation to exposure from dental amalgam fillings. Swed Dent J
1987;11:179-187

40 Dondero F, Lenzi A, Lombardo F, Gandini L; Therapy of immunologic
infertiilty. Acta Eur Fertil 1991;22:139-145

41 Rowlands AS, Baird DD, Weinberg CP, Shore DL, Shy CM, Wilcos AJ. The effect
of occupational exposure to mercury vapor on the fertility of female dental
assistants. Occup Environ Med 1994;51:28-34.

42 Gerhard I, Monga B, Waldbrenner A, Runnebaum B Heavy metals and fertility. J
Toxicol Environ Health 1998;21;54(8):593-611

43 Gerhard I, Frick A, Monga B: Diagnosis of mercury body burden. Clin Lab
1997;43:637-647

44 Duhr E, Pendergrasss C, Kasarskis E, Slevin J Haley B; Mercury induces
GTP-tubulin interactions in rat brain similar to those observed in Alzheimer's
disease. FASEB J 1991; 5:456.

45 Hultman P, Johansson U, Turle S,J, et al: Adverse immunological effects and
autoimmunity induced by dental amalgam and alloy in mice. FASEB J
1994;8:1183-1190

46 Siblered TL, Kienholz E. Evidence that mercury from silver dental fillings
may be an etiological factor in reduced nerve conduction velocity in multiple
sclerosis patients. Journal of Orthomolecular Medicine 1997;12(3):169-172.

47 Barregard L, Lindtedt G, Shutz A, et al. Endocrine function in mercury
exposed chloralkali owkers. Occup Environ Med 1994, 51 (8)536-540.

48 Moszczynski P, Lisiewica J, Bartus R, et al. Lymphocytes T and NK cells in
men occupationally exposed to mercury vapors. Int J Occup Med Environ Health
1995 8(1):49-56.

49 Summers AO, Wireman J, Vimy MI, Lorscheider FI, Marshall B, Levy SB, et al;
Mercury released from dental Asilver@ fillings provokes an increase in mercury
and antibiotic-resistant bacteria in oral and intestinal floras of primates.
Antimicrob Agents and Chemother 1993;37:825-834

50 Escheverria D, Hever N, Martin MD, Naleway CA, Woods JS Bittner AC;
Behavioral effects of low level exposure to mercury among dentists. Neurotxicol
Teratol 1995;17:161-168

51 Ngim CH: Chronic neurobiological effects of elemental mercury in dentists.
Br J Indust Med 1992;49:782-790

52 Siblerud RL; The relationship between mercury from dental amalgam and mental
health. Am J Psychotherapy 1989;18:575-587

53 Powell JE, Edwards A, Edwards M, et al. Changes in the incidence of
childhood autism and other autistic spectrum disorders in preschool children
from two areas of the West Midlands, UK. Dev Med Child Neurol. 2000
Sep;42(9):624-8.

54 Tanguay PE. Pervasive developmental disorders: a 10-year review. J Am Acad
Child Adolesc Psychiatry. 2000 Sep;39(9):1079-95.

55 Rice D, Barone S Jr. Critical periods of vulnerability for the developing
nervous system: evidence from humans and animal models. Environ Health
Perspect. 2000 Jun;108 Suppl 3:511-33.

56 Frustaci A, Magnavita N, Chimenti C, et. al; Marked elevation of myocardial
trace elements in idiopathic dilated cardiomyopathy. J Am Coll Cardiology
1999;33:1578-83

57 Chang YC, Yeh C, Wang JD. Subclinical neurotoxicity of merucyr vapor
revcelaed by a multimodality evoked potential study of chloralkali workers.
Amer J Ind Med 1995;27(2):271-279.

58 Yang Y-J, Huang C-C, Shih T-S, et al . Chronic elemental mercury
intoxication:clinical and field studies in lampsocked manufacturers. 1994;Occup
Environ Med 57(1):245-247.

59 Bluhm RE, Bobbitt RG, Wlech LW, et al. Elemental mercury vapour toxicity,
treatment and prognosis after acute intensive exposure in chloraklali plant
workers. Part 1I. History, neuropsychological findings and chelator effects.
Hum Exp Toxicol 1992 11(3):201-210.

60 Clarkson TW. Mercury. 1989; J Am Coll Toxicol 8(7):1291-1296.

61 Eley BM The future of dental amalgam: A review of the literature. Part 2:
Mercury exposure in dental practice. Br Dent J 1997;182(8):293-7.

62 Petrunkin VE: Synthesis and properties of demercapto derivatives of
alkylsulfonic acids. Toksikol mosc 1958;21: 53-59

63 Torres-Alanis O, Garza-Ocanas L, Pineyro-Lopez A. Evaluation of urinary
mercury excretion after administration of 2,3-dimercapto-1-propane sulfonic
acid to occupationally exposed men. J Toxicol Clin Toxicol 1995;33(6):717-720

64 Aaseth J, Jacobsen D, Andersen O, Wickstrom E. Treatment of mercury and lead
poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate.
1995;120(3):853-854

65 Aposhian HV, Maiorino RM, Rivera M, et al Human studies with the chelating
agents, DMPS and DMSA. J Toxicol Clin Toxicol 1992;30(4):505-528

66 Aposhian HV, Aposhia MM. Meso-2,3 dimercaptosuccinic acid: chemical,
pharmacological and toxicological properties of an orally effective metal
chelating agent. Annu Rev Toxicol 1990;30:279-306

67 Lorscheider FL, Vimy MJ. Evaluation of the saftey issue of mercury release
from dental fillings. FASEB J 1993;7:432-1433

68 Aposhian VK: Mobilization of Mercury and Arsenic in Humans by Sodium 2,3
Dimercapto-1-propane Sulfonate (DMPS). Environ Health Perspect 1998;106(Suppl
4):1017-1025

69 Crinnion WJ. Environmental medicine, part three: long-term effects of
chronic low-dose mercury exposure Altern Med Rev 2000 Jun;5(3):209-23

70 Schiele R, Schaller KH, Welte D: Mobilization of mercury reserves in the
organism by means of DMPS. Occup Med Soc Med Prevent Med 1989;24: 249-251

71 Kidd RF Results of dental amalgam removal and mercury detoxification using
DMPS and neural therapy. Altern Ther Health Med 2000 Jul;6(4):49-55

72 Belles M, Sanchez DJ, Gomez M, Domingo JL, Jones MM, Singh PK Assessment of
the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against
methylmercury-induced maternal and embryo/fetal toxicity in mice. Toxicology
1996;106(1-3):93-97

73Kostial K, Restek-Samarzija N, Blanusa M, Piasek M, Prester L, Jones MM,
Singh PK Racemic-2,3-dimercaptosuccinic acid for inorganic mercury mobilization
in rats. J Appl Toxicol 1997;17(1):71-74

74 Gerhard I; Runnebaum B: Schadstoffe und Fertiliatatsstorungen Schwermetalle
und Mineralstoffe. Geburtshilfe Frauenheillkd 1992;52:383-396, 509-515

75 Baum CR Treatment of mercury intoxication. Curr Opin Pediatr 1999
Jun;11(3):265-8

76 Vamnes JS, Eide R, Isrenn R, Hol PJ et al. Diagnostic value of a chelating
agent in patients with symptoms allegedly caused by amalgam fillings.J Dent Res
2000 Mar;79(3):868-74

77 Sallsten G, Barregard L, Schutz A Clearance half life of mercury in urine
after the cessation of long term occupational exposure: influence of a
chelating agent (DMPS) on excretion of mercury in urine. Occup Environ Med
1994;51(5):337-342

78 Afonne OJ, Orisakwe OE, Ndubuka GI, et al. Zinc protection of
mercury-induced hepatic toxicity in mice. Biol Pharm Bull 2000 Mar;23(3):305-8

79 Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, et al. Mobilization of heavy
metals by newer, therapeutically useful chelating agents. Toxicology
1995;31;97(1-3):23-38

80 Gonzalez-Ramirez D, Maiorino RM, Zuniga-Charles M, et al Sodium
2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II.
Urinary mercury, porphyrins and neurobehavioral changes of dental workers in
Monterrey, Mexico. J Pharmacol Exp Ther 1995;272(1):264-274

81 Kostial K, Restek-Samarzija N, Blanusa M, Piasek M, Jones MM, Singh PK
Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for
removal of mercury in rats. Pharmacol Toxicol 1997;81(5):242-244

82 Miller AL. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble
treatment for heavy metal toxicity. Altern Med Rev. 1998;3(3): 199-207

83 Hurlbut KM, Maiorino RM, Mayersohn M, Dart RC, Bruce DC, Aposhian HV
Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics
of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human
volunteers. J Pharmacol Exp Ther 1994;268(2):662-668

84 Zheng W, Maiorino RM, Brendel K, Aposhia HV. Determination and metabolism of
dithiol chelating agents. Fundam Appl Toxicol 1990;14:598-607

85 Aposhian HV. Mobilization of mercury and arsenic in humans by sodium
2,3-dimercapto-1-propane sulfonate. Environ Health Perspect 1998;106 Suppl
4:1017-1025

86 Research data presented at the annual meeting of the Australasian Society of
Oral medicine and Toxicology in Sydney, Australia, Sept.1998

87 H.B.Xue, W.Stumm, L.Sigg: The binding of Heavy Metals to Algal Surfaces,
Water Res 1988;22, 917

88 Ahner, AB, Kong KS, Morell MM, Phytochelatin production in marine algea: An
interspecies comparison. Limnol Oceanograph 1995;40: 649-657

89 Carr HP, et al. Characterization of the cadmium-binding capacity of
Chlorella vulgaris. Bull Environ Contam Toxicol. 1998;60(3): 433-440

90 M. Tsezos: Biosorption of Radioactive Species, in: Biosorption of Heavy
Metals, pp 45-50 editied by B.Volesky, CRC Press(1990)

91 M.Kraft: Bindungsverhalten von Arsen, Cadmium, Chrom, Quecksilber, Nickel
und Blei an schwerverdauliche Lebensmittel und Lebensmittelkomponenten in
kuenstlichem Magen-Darm-Saft. PhD Thesis. Institut fuer Hygiene, Sozial-und
umweltmedizin der Ruhr-Universitaet Bochum, Germany, (1998)

92 Klinghardt, D: Amalgam/Mercury Detox as a Treatment for Chronic Viral,
Bacterial, and Fungal Illnesses Explore! Volume 1997;8, No 3

93 R.Muzzarelli, O.Tubertini: Chitin and chitosan on chromatographic supports
and adsorbents for collection of metal ions from organic and aqueous solutions
and sea water, Talanta, 1969;16, 1571 ff

94 Y.Subramanian, T.Yoshinar: Studies on the formation of chitin-metal
complexes, Rep.No 27, Marine Sciences Center, Mc Gill Univ, Montreal (1974)

95 J.W.Park, M.O. Park: Mechanism of metal ion binding to chitosan in solution,
cooperative inter- and intramolecular chelations. Bull.Korean Chem.Soc.
1984;5(3), 108

96 Omura Y, Beckman SL Role of mercury (Hg) in resistant infections & effective
treatment of Chlamydia trachomatis and Herpes family viral infections (and
potential treatment for cancer) by removing localized Hg deposits with Chinese
parsley and delivering effective antibiotics using various drug uptake
enhancement methods. Acupunct Electrother Res. 1995;20(3-4): 195-229

97 Omura Y, Shimotsuura Y, Fukuoka A, Fukuoka H, Nomoto T. Significant mercury
deposits in internal organs following the removal of dental amalgam, &
development of pre-cancer on the gingiva and the sides of the tongue and their
represented organs as a result of inadvertent exposure to strong curing light
(used to solidify synthetic dental filling material) & effective treatment: a
clinical case report, along with organ representation areas for each tooth.
Acupunct Electrother Res. 1996 ;21(2): 133-160.

98 Ewan KB, Pamphlett R Increased inorganic mercury in spinal motor neurons
following chelating agents. Neurotoxicology 1996;17(2):343-349

99 Cha CW A study on the effect of garlic to the heavy metal poisoning of rat.
J Korean Med Sci 1987;2(4):213-224

100 Lee JH, Kang HS, Roh Protective effects of garlic juice against
embryotoxicity of methylmercuric chloride administered to pregnant Fischer 344
rats. J Yonsei Med J 1999 Oct;40(5):483-9

101 The Miracle of MSM The Natural Solution for Pain. Jacob, S., Lawrence, RM,
Zucker, M. Penguin Putnam, New York, NY 1999.

102 Stjernberg L, Berglund J. Garlic as an insect repellent. JAMA. 2000 Aug
16;284(7):831.

103 Fleischauer AT, Poole C, Arab L. Garlic consumption and cancer prevention:
meta-analyses of colorectal and stomach cancers. Am J Clin Nutr. 2000
Oct;72(4):1047-52.

104 Morelli V, Zoorob RJ. Alternative therapies: Part II. Congestive heart
failure and hypercholesterolemia. Am Fam Physician. 2000 Sep 15;62(6):1325-30.

105 Chang, L.W , Gilbert,M and Sprecher,J: Modification of methylmercury
neurotoxicity by vitamin E, Environ.Res. 1978;17:356-366

106 Yoneda S, Suzuki KT Detoxification of mercury by selenium by binding of
equimolar Hg-Se complex to a specific plasma protein. Toxicol Appl Pharmacol
1997;143(2):274-280

107 Akesson I, Ingrid B; Status of mercury and selenium in dental personnel:
Impact of amalgam work and own fillings. Arch Environ Health 1991;46(2):103-109

108 Johansson E: Selenium and its protection against the effects of mercury and
silver. J Trace Elements 1991;5:273-274

109 Gailer J; George GN; Pickering IJ, et al. Structural Basis of the
Antagonism between Inorganic Mercury and Selenium in Mammals. Chem Res Toxicol
2000 Nov 20;13(11):1135-1142

110 Hultberg B, Andersson A, Isaksson A Thiol and redox reactive agents exert
different effects on glutathione metabolism in HeLa cell cultures.Clin Chim
Acta 1999 May;283(1-2):21-32

111 Westphal GA; Schnuch A; Schulz TG, et al. Homozygous gene deletions of the
glutathione S-transferases M1 and T1 are associated with thimerosal
sensitization. Int Arch Occup Environ Health 2000 Aug;73(6):384-8.

112 Schurz(1) F; Sabater-Vilar M; Fink-Gremmels J. Mutagenicity of mercury
chloride and mechanisms of cellular defence: the role of metal-binding
proteins. Mutagenesis 2000 Nov;15(6):525-530

113 Anuradha B, Varalakshmi P Protective role of DL-alpha-lipoic acid against
mercury-induced neural lipid peroxidation. Pharmacol Res 1999 Jan;39(1):67-80

114 Ballatori N, Lieberman MW, Wang W N-acetylcysteine as an antidote in
methylmercury poisoning. Environ Health Perspect 1998 May;106(5):267-71

115 Dirks M, Marvin J; Mercury excretion and intravenous ascorbic acid. Arch
Environ Health 1994;49(1):49-52

116 Hill, CH. Interactions of vitamin C with lead and mercury. Ann N Y Acad Sci
1980;355:262-6
117 Yamini B, Sleight SD. Effects of ascorbic acid deficiency on methyl mercury
dicyandiamide toxicosis in guinea pigs J Environ Pathol Toxicol Oncol 1984
Jul;5(4-5):139-50

118 Zorn NE, Smith JT A relationship between vitamin B12, folic acid, ascorbic
acid, and mercury uptake and methylation.Life Sci 1990;47(2):167-73

119 Sorg O, Schilter B, Honegger P, et. al. Increased vulnerability of neurones
and glial cells to low concentrations of methylmercury in a prooxidant
situation. Acta Neuropathol (Berl) 1998 Dec;96(6):621-7

120 Iyengar GV; Nair PP. Global outlook on nutrition and the environment:
meeting the challenges of the next millennium. Sci Total Environ 2000 Apr
17;249(1-3):331-46.

121 Chen WY, Abatangelo G.Functions of hyaluronan in wound repair. Wound Repair
Regen 1999;7(2):79-89

122 Delpech B, Girard N, Bertrand P, Courel MN, Chauzy C, Delpech Hyaluronan:
fundamental principles and applications in cancer. J Intern Med
1997;242(1):41-8

123 Sutherland IW. Novel and established applications of microbial
polysaccharides. Trends Biotechnol 1998;16(1):41-6

124 Knudson CB, Nofal GA, Pamintuan L, Aguiar DJ: The chondrocyte pericellular
matrix: a model for hyaluronan-mediated cell-matrix interactions. Biochem Soc
Trans 1999;27(2):142-